Vote for Prof. Andrew Sewell

Andrew Sewell 's team has traditionally focused on T-cell ligands and the receptors that recognize them.

More recently, they have become interested in precisely what T-cells target during successful immunotherapy for solid cancer or during natural spontaneous remission. This has necessitated that we build pipelines for the discovery of what T-cell receptors (TCRs) of unknown specificity recognise.

These pipelines have enabled them to determine that many of the T-cells from these remarkable patients have capacity to recognize most forms of cancer via new mechanisms. They aim to use these TCRs and the ligands they recognise to build the next generation of cancer therapies.

Check out their team page and vote for them! https://www.molecularcloud.org/researchawards2023/detail/andrew-sewell